Professional organizations representing healthcare information technology managers and staff are divided on whether to delay or move forward with Stage 2 of the meaningful use program. The College of Healthcare Information Management Executives has called for a delay, while the Healthcare Information and Management Systems Society has urged providers to act now. Various other organizations have different concerns and suggestions for the program. Overall, the decision on whether to move forward or delay is up to each healthcare organization.
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
